BTIS
REGN icon

BB&T Investment Services’s Regeneron Pharmaceuticals REGN Stock Holding History

BB&T Investment Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$803K Buy
2,114
+558
+36% +$226K 0.13% 154
2017
Q3 		$702K Buy
1,556
+505
+48% +$240K 0.14% 146
2017
Q2 		$503K Buy
1,051
+404
+62% +$177K 0.13% 151
2017
Q1 		$248K Buy
647
+594
+1,121% +$220K 0.1% 180
2016
Q4 		$20K Buy
+53
New +$20.2K 0.01% 420

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

BB&T Investment Services's REGN Position: Q4 2017 in Review

BB&T Investment Services increased its Regeneron Pharmaceuticals (REGN) stake by 36% in Q4 2017, buying an estimated $226K and bringing the position to 2,114 shares worth $803K. The position accounts for 0.13% of the portfolio, ranked #154.

BB&T Investment Services first reported a position in REGN in Q4 2016 and has held it in 5 quarters since. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • BB&T Investment Services held 2,114 shares of Regeneron Pharmaceuticals worth $803K as of Q4 2017.
  • BB&T Investment Services bought 558 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $226K.
  • Regeneron Pharmaceuticals made up 0.13% of BB&T Investment Services's portfolio in Q4 2017, its #154 holding.
  • BB&T Investment Services first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.